Latest Information Update: 24 Jun 2001
At a glance
- Originator NicOx
- Mechanism of Action Cyclooxygenase inhibitors; Nitric oxide donors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Colorectal cancer
Most Recent Events
- 24 Jun 2001 Discontinued-Preclinical for Colorectal cancer in France (Unknown route)
- 05 Nov 1998 Preclinical development for Colorectal cancer in France (Unknown route)
- 05 Nov 1998 New profile